Klausner, R. D., Fauci, A. S., Corey, L., Nabel, G. J., Gayle, H., Berkley, S., … Wasserheit, J. N. (2004). The challenges of an HIV vaccine enterprise - Response. SCIENCE, 303(5662), 1296–1297.

Klausner, R. D., A. S. Fauci, L. Corey, G. J. Nabel, H. Gayle, S. Berkley, B. F. Haynes, et al. “The challenges of an HIV vaccine enterprise - Response.” SCIENCE 303, no. 5662 (February 27, 2004): 1296–97.

Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, Berkley S, et al. The challenges of an HIV vaccine enterprise - Response. SCIENCE. 2004 Feb 27;303(5662):1296–7.

Klausner, R. D., et al. “The challenges of an HIV vaccine enterprise - Response.” SCIENCE, vol. 303, no. 5662, AMER ASSOC ADVANCEMENT SCIENCE, Feb. 2004, pp. 1296–97.

Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, Berkley S, Haynes BF, Baltimore D, Collins C, Douglas RG, Esparza J, Francis DP, Ganguly NK, Gerberding JL, Johnson MI, Kazatchkine MD, McMichael AJ, Makgoba MW, Pantaleo G, Piot P, Shao YM, Tramont E, Varmus H, Wasserheit JN. The challenges of an HIV vaccine enterprise - Response. SCIENCE. AMER ASSOC ADVANCEMENT SCIENCE; 2004 Feb 27;303(5662):1296–1297.